Table 4.
Effect of (−)-HCA on liver homogenates concentration of triglycerides (TG), hepatic lipase (HL), non-esterified fatty acid (NEFA)
| Item | Supplemental (−)-HCA (mg/kg) | |||
|---|---|---|---|---|
| 0 | 1000 | 2000 | 3000 | |
| TG (mmol/g liver) | 3.31 ± 0.56 | 2.78 ± 0.40 | 2.75 ± 0.58 | 2.02 ± 0.34* |
| NEFA (μmol/L) | 65.83 ± 5.66 | 95.41 ± 9.52 | 109.90 ± 19.21* | 125.52 ± 12.37** |
| HL (U/mL) | 1.57 ± 0.11 | 1.59 ± 0.09 | 3.41 ± 0.27** | 2.68 ± 0.28** |
| Hepatic glycogen (mg/g liver) | 2.63 ± 0.23 | 3.63 ± 0.34 | 3.91 ± 0.41* | 3.91 ± 0.65* |
Values are means ± SE. Each (−)-HCA treated group represent 12 chickens at the age of 49 days. * P < 0.05, ** P < 0.01 compared with the control group